Outcomes of the phase 2 study are expected later this year
Shah AM, Cikes M, Prasad N, Li G, Getchevski S, Glaggett B, et al
A structured checklist and timeframesuch as contacting a clinician after 12 weeks of persistent moderate nausea despite conservative measuresaligns patient expectations with clinical practice
Athletes should choose NSF Certified for Sport or Informed-Sport supplements
The market for GLP-1 RAs is dominated by Novo Nordisk, Eli Lilly, AstraZeneca, Bristol Myers Squibb and GSK
By prolonging the time it takes for food to leave the stomach, GLP-1 drugs increase feelings of fullness and reduce appetite, leading to decreased food intake and ultimately, for many, weight loss